NR565/ NR 565 FINAL EXAM ADVANCED PHARMACOLOGY
2026 EXAM COMPLETE 220 QUESTIONS WITH DETAILED
VERIFIED ANSWERS (100% CORRECT) /ALREADY GRADED A+
CHAMBERLAIN A newly pregnant mother's understanding of
hypothyroidism - ANSW..Increase dose up to 50%
General Prescribing Principles & Legal/Ethical Foundations
Question Answer Options Correct Answer & Rationale
A. It is identical in
every state. C. It is defined by each state’s
B. It is determined by practice act and regulatory board
federal nursing Prescriptive authority is state-
1. Which statement best
regulations. specific, set by statutes and rules
describes APRN prescriptive
C. It is defined by each state practice acts and regulatory
authority in the United
state’s practice act boards. The DEA regulates
States?
and regulatory controlled substances at the fede
boards. level but does not define all aspe
D. It is determined of APRN prescriptive authority .
solely by the DEA.
2. An APRN wishes to A. State Board of C. Drug Enforcement
prescribe a Schedule II opioid. Nursing Administration (DEA)
Which agency must have B. Centers for The DEA issues registration numb
issued the provider’s DEA Medicare & Medicaid that authorize clinicians to prescr
number? Services (CMS) controlled substances. State boar
,Question Answer Options Correct Answer & Rationale
C. Drug Enforcement govern licensure and scope, but a
Administration (DEA) DEA number is needed to legally
D. Food and Drug prescribe scheduled drugs .
Administration (FDA)
A. It is encouraged to
reduce health-care
C. It should be avoided except in
costs.
true emergencies.
B. It is acceptable for
Prescribing for yourself or family
3. Which of the following chronic conditions
members should generally be
best reflects best practice only.
avoided due to impaired objectiv
regarding prescribing for C. It should be
inadequate assessment, and ethi
family members? avoided except in true
concerns. Exceptions may occur i
emergencies.
emergencies when no other
D. It is acceptable if
provider is reasonably available .
the APRN documents
consent.
A. Brand name B. Potential drug–drug interactio
recognition and Beers Criteria
4. An APRN is choosing an
B. Potential drug–drug In older adults, polypharmacy an
antihypertensive for an older
interactions and Beers age-related physiologic changes
adult on multiple
Criteria increase the risk of adverse even
medications. Which
C. How often samples Reviewing interactions and the
consideration is most critical
are available Beers Criteria (a list of potentially
to review before prescribing?
D. Whether the drug is inappropriate medications in olde
new to the market adults) reduces the risk of harm .
A. Current clinical D. Pharmaceutical company
5. Which factor is least
guidelines marketing
appropriate as the primary
B. Patient Evidence-based prescribing relies
,Question Answer Options Correct Answer & Rationale
basis for choosing a comorbidities guidelines, safety, and patient-
medication? C. Drug–drug specific factors. Marketing and sa
interaction profile promotions should not drive
D. Pharmaceutical prescribing decisions .
company marketing
Pharmacokinetics, Pharmacodynamics, & Special Populations
Question Answer Options Correct Answer & Rationale
A. Increased lean
mass, increased
albumin
B. Decreased lean mass, decreased
B. Decreased lean
albumin, decreased body fat
mass, decreased
6. Distribution in the In the elderly, decreased lean mass,
albumin, decreased
elderly can be affected in decreased albumin (protein binding)
body fat
what ways? and decreased body fat affect how
C. Increased gastric
medication is absorbed, distributed,
acidity, faster
stored, leading to a delayed response
absorption
D. Increased body fat,
increased lean mass
7. A patient with liver A. Increase the dose B. Decrease the dose
cirrhosis is prescribed a B. Decrease the dose Impaired hepatic function leads to
medication extensively C. No adjustment decreased medication metabolism,
metabolized hepatically. needed causing increased drug levels in the
Which dosage adjustment D. Double the body which can lead to toxicity. A low
is most likely? frequency dose is usually required .
, Question Answer Options Correct Answer & Rationale
A. The time it takes
for the drug to start B. The range between the minimum
working effective dose and the minimum tox
B. The range between dose
the minimum The therapeutic window is the dosag
8. What is the therapeutic effective dose and range between the amount that give
window of a drug? the minimum toxic an effect and the amount that gives
dose more adverse effects than desired
C. The total amount of effects. Medications with a small
drug absorbed window must be administered with c
D. The rate of drug and frequent monitoring .
excretion
A. A membrane that
allows all drugs to
enter the brain
B. A barrier that B. A barrier that impedes entry of dr
impedes entry of into the brain, limiting passage to lip
drugs into the brain, soluble drugs
9. What is the Blood Brain limiting passage to The BBB impedes entry of drugs into
Barrier (BBB)? lipid-soluble drugs brain. Passage is limited to lipid-solub
C. A structure that drugs (e.g., seizure, pain meds). Prot
only allows protein- bound or highly ionized drugs cannot
bound drugs to pass cross .
D. A mechanism that
speeds up drug
metabolism
Infectious Disease and Vaccines
2026 EXAM COMPLETE 220 QUESTIONS WITH DETAILED
VERIFIED ANSWERS (100% CORRECT) /ALREADY GRADED A+
CHAMBERLAIN A newly pregnant mother's understanding of
hypothyroidism - ANSW..Increase dose up to 50%
General Prescribing Principles & Legal/Ethical Foundations
Question Answer Options Correct Answer & Rationale
A. It is identical in
every state. C. It is defined by each state’s
B. It is determined by practice act and regulatory board
federal nursing Prescriptive authority is state-
1. Which statement best
regulations. specific, set by statutes and rules
describes APRN prescriptive
C. It is defined by each state practice acts and regulatory
authority in the United
state’s practice act boards. The DEA regulates
States?
and regulatory controlled substances at the fede
boards. level but does not define all aspe
D. It is determined of APRN prescriptive authority .
solely by the DEA.
2. An APRN wishes to A. State Board of C. Drug Enforcement
prescribe a Schedule II opioid. Nursing Administration (DEA)
Which agency must have B. Centers for The DEA issues registration numb
issued the provider’s DEA Medicare & Medicaid that authorize clinicians to prescr
number? Services (CMS) controlled substances. State boar
,Question Answer Options Correct Answer & Rationale
C. Drug Enforcement govern licensure and scope, but a
Administration (DEA) DEA number is needed to legally
D. Food and Drug prescribe scheduled drugs .
Administration (FDA)
A. It is encouraged to
reduce health-care
C. It should be avoided except in
costs.
true emergencies.
B. It is acceptable for
Prescribing for yourself or family
3. Which of the following chronic conditions
members should generally be
best reflects best practice only.
avoided due to impaired objectiv
regarding prescribing for C. It should be
inadequate assessment, and ethi
family members? avoided except in true
concerns. Exceptions may occur i
emergencies.
emergencies when no other
D. It is acceptable if
provider is reasonably available .
the APRN documents
consent.
A. Brand name B. Potential drug–drug interactio
recognition and Beers Criteria
4. An APRN is choosing an
B. Potential drug–drug In older adults, polypharmacy an
antihypertensive for an older
interactions and Beers age-related physiologic changes
adult on multiple
Criteria increase the risk of adverse even
medications. Which
C. How often samples Reviewing interactions and the
consideration is most critical
are available Beers Criteria (a list of potentially
to review before prescribing?
D. Whether the drug is inappropriate medications in olde
new to the market adults) reduces the risk of harm .
A. Current clinical D. Pharmaceutical company
5. Which factor is least
guidelines marketing
appropriate as the primary
B. Patient Evidence-based prescribing relies
,Question Answer Options Correct Answer & Rationale
basis for choosing a comorbidities guidelines, safety, and patient-
medication? C. Drug–drug specific factors. Marketing and sa
interaction profile promotions should not drive
D. Pharmaceutical prescribing decisions .
company marketing
Pharmacokinetics, Pharmacodynamics, & Special Populations
Question Answer Options Correct Answer & Rationale
A. Increased lean
mass, increased
albumin
B. Decreased lean mass, decreased
B. Decreased lean
albumin, decreased body fat
mass, decreased
6. Distribution in the In the elderly, decreased lean mass,
albumin, decreased
elderly can be affected in decreased albumin (protein binding)
body fat
what ways? and decreased body fat affect how
C. Increased gastric
medication is absorbed, distributed,
acidity, faster
stored, leading to a delayed response
absorption
D. Increased body fat,
increased lean mass
7. A patient with liver A. Increase the dose B. Decrease the dose
cirrhosis is prescribed a B. Decrease the dose Impaired hepatic function leads to
medication extensively C. No adjustment decreased medication metabolism,
metabolized hepatically. needed causing increased drug levels in the
Which dosage adjustment D. Double the body which can lead to toxicity. A low
is most likely? frequency dose is usually required .
, Question Answer Options Correct Answer & Rationale
A. The time it takes
for the drug to start B. The range between the minimum
working effective dose and the minimum tox
B. The range between dose
the minimum The therapeutic window is the dosag
8. What is the therapeutic effective dose and range between the amount that give
window of a drug? the minimum toxic an effect and the amount that gives
dose more adverse effects than desired
C. The total amount of effects. Medications with a small
drug absorbed window must be administered with c
D. The rate of drug and frequent monitoring .
excretion
A. A membrane that
allows all drugs to
enter the brain
B. A barrier that B. A barrier that impedes entry of dr
impedes entry of into the brain, limiting passage to lip
drugs into the brain, soluble drugs
9. What is the Blood Brain limiting passage to The BBB impedes entry of drugs into
Barrier (BBB)? lipid-soluble drugs brain. Passage is limited to lipid-solub
C. A structure that drugs (e.g., seizure, pain meds). Prot
only allows protein- bound or highly ionized drugs cannot
bound drugs to pass cross .
D. A mechanism that
speeds up drug
metabolism
Infectious Disease and Vaccines
